0001214659-21-011794.txt : 20211115
0001214659-21-011794.hdr.sgml : 20211115
20211115160121
ACCESSION NUMBER: 0001214659-21-011794
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211115
DATE AS OF CHANGE: 20211115
EFFECTIVENESS DATE: 20211115
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Octagon Capital Advisors LP
CENTRAL INDEX KEY: 0001839435
IRS NUMBER: 843576791
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20958
FILM NUMBER: 211410094
BUSINESS ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-369-2829
MAIL ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001839435
XXXXXXXX
09-30-2021
09-30-2021
false
Octagon Capital Advisors LP
654 MADISON AVENUE
16TH FLOOR
NEW YORK
NY
10065
13F HOLDINGS REPORT
028-20958
N
Justin Hirsch
Chief Compliance Officer and Chief Financial Officer
212-369-2829
/s/ Justin Hirsch
New York
NY
11-15-2021
0
30
406144
INFORMATION TABLE
2
infotable.xml
4D MOLECULAR THERAPEUTICS IN
COM
35104E100
22419
831267
SH
SOLE
831267
0
0
AMBRX BIOPHARMA INC
SPONSORED ADS
02290A102
4725
350000
SH
SOLE
350000
0
0
APELLIS PHARMACEUTICALS INC
COM
03753U106
52601
1595911
SH
SOLE
1595911
0
0
ARCUS BIOSCIENCES INC
COM
03969F109
33830
970164
SH
SOLE
970164
0
0
ARVINAS INC
COM
04335A105
13847
168500
SH
SOLE
168500
0
0
AVIDITY BIOSCIENCES INC
COM
05370A108
11001
446641
SH
SOLE
446641
0
0
BRIDGEBIO PHARMA INC
COM
10806X102
26688
569414
SH
SOLE
569414
0
0
CARDIFF ONCOLOGY INC
COM
14147L108
6545
982753
SH
SOLE
982753
0
0
CELLDEX THERAPEUTICS INC NEW
COM NEW
15117B202
41108
761398
SH
SOLE
761398
0
0
CENTURY THERAPEUTICS INC
COM
15673T100
15162
602623
SH
SOLE
602623
0
0
CONNECT BIOPHARMA HLDGS LTD
ADS
207523101
7795
326143
SH
SOLE
326143
0
0
CURIS INC
COM NEW
231269200
17968
2294721
SH
SOLE
2294721
0
0
CYTEK BIOSCIENCES INC
COM
23285D109
10705
500000
SH
SOLE
500000
0
0
DESIGN THERAPEUTICS INC
COM
25056L103
219
14926
SH
SOLE
14926
0
0
DYNE THERAPEUTICS INC
COM
26818M108
9478
583649
SH
SOLE
583649
0
0
EDGEWISE THERAPEUTICS INC
COM
28036F105
830
50000
SH
SOLE
50000
0
0
GOSSAMER BIO INC
COM
38341P102
19020
1513138
SH
SOLE
1513138
0
0
HELIX ACQUISITION CORP
COM CL A
G4444C102
3948
400000
SH
SOLE
400000
0
0
I MAB
SPONSORED ADS
44975P103
55416
764461
SH
SOLE
764461
0
0
IKENA ONCOLOGY INC
COM
45175G108
3471
275000
SH
SOLE
275000
0
0
IVERIC BIO INC
COM
46583P102
4499
277057
SH
SOLE
277057
0
0
JIYA ACQUISITION CORP
COM CL A
47760M102
2934
300000
SH
SOLE
300000
0
0
MONTE ROSA THERAPEUTICS INC
COM
61225M102
3342
150000
SH
SOLE
150000
0
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
4204
200000
SH
SOLE
200000
0
0
OMEGA THERAPEUTICS INC
COMMON STOCK
68217N105
6980
370279
SH
SOLE
370279
0
0
PMV PHARMACEUTICALS INC
COM
69353Y103
2984
100141
SH
SOLE
100141
0
0
PROMETHEUS BIOSCIENCES INC
COM
74349U108
4742
200000
SH
SOLE
200000
0
0
STOKE THERAPEUTICS INC
COM
86150R107
7551
296822
SH
SOLE
296822
0
0
TENAX THERAPEUTICS INC
COM NEW
88032L209
54
30600
SH
SOLE
30600
0
0
VERA THERAPEUTICS INC
CL A
92337R101
12078
696126
SH
SOLE
696126
0
0